![]() |
市場調查報告書
商品編碼
1827705
2025年全球骨質密度檢測設備市場報告Bone Densitometer Global Market Report 2025 |
近年來,骨質密度檢測設備市場規模強勁成長,從2024年的13.5億美元增加至2025年的14.5億美元,複合年成長率為7.2%。預測期內的成長可歸因於人口老化、人們對骨骼健康重要性的認知不斷提高、醫療基礎設施的完善以及經濟成長。
預計未來幾年骨質密度檢測設備市場將快速成長,到2029年將達到21.7億美元,複合年成長率為10.7%。預測期內的成長歸因於預防性醫療保健的增加、研發的活性化、醫療保健支出的增加以及骨質疏鬆症盛行率的上升。預測期內的主要趨勢包括人工智慧 (AI) 整合、永續性和綠色技術、穿戴式骨骼健康監測、患者參與解決方案以及遠端監控。
骨質密度檢測設備是一種用於測量骨骼密度的醫療設備,它提供有關骨骼健康的重要資訊。骨質密度檢測設備常用於醫院和診斷中心,它使用先進的X光技術來評估骨骼的礦物學和密度。
主要的骨質密度檢測設備類型包括 DXA 系統 (雙能量 X光檢測法)、周邊骨骨密度儀、X光吸收掃描儀和定量超音波掃描儀。 DXA 系統是用於測量骨骼密度的先進 X 光技術。該技術使用極少量的電離輻射來產生身體內部影像,有助於評估骨質流失。骨質密度檢測設備用於各種醫療保健場所,包括醫院、診所、診斷中心和影像中心。它們可用於診斷骨質疏鬆症、骨質缺乏症和類風濕性關節炎等疾病,以及測量身體組成。
2025年春季,美國關稅突然上調及其引發的貿易摩擦對醫療設備產業產生了重大影響,尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價,製造商面臨利潤壓力。監管挑戰進一步加劇了形勢,因為由於關稅而更換供應商通常需要醫療設備重新認證,導致市場准入延遲。為此,企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。
本研究報告是商業研究公司(The Business Research Company)新報告系列的一部分,該系列提供骨質密度檢測設備市場統計數據,包括全球市場規模、各地區市場佔有率、骨質密度檢測設備市場佔有率競爭對手、詳細的骨質密度檢測設備細分市場、市場趨勢和商業機會,以及在骨質密度檢測設備行業取得成功所需的數據。本骨質密度檢測設備骨質密度檢測設備研究報告提供了全面的市場展望,並對行業現狀和未來趨勢進行了詳細分析。
我們對該市場未來五年10.7%的成長率預測與先前保持不變。下滑的主要原因是美國與其他國家之間關稅的影響。這種影響可能會直接波及美國,導致雙能量X光吸收儀(DEXA)組件和精密校準模型的供應鏈中斷,這些組件和模型主要來自日本和瑞士等主要地區,這可能導致骨質疏鬆症診斷延遲,並增加醫療機構的資本成本。由於互惠關稅以及貿易緊張局勢和限制措施升級對全球經濟和貿易的負面影響,這種影響也可能更為廣泛。
骨質疏鬆症的日益普及預計將推動對骨質密度檢測設備的需求。骨質疏鬆症的特徵是骨骼密度和強度下降,導致骨質脆弱,可歸因於低鈣攝取、遺傳性疾病和胃腸手術等因素。骨質密度檢測設備在透過特定技術和應用計算定量骨骼密度方面發揮關鍵作用,有助於骨質疏鬆症的診斷和治療。根據安進公司在 2022 年的報告,估計每年有 150 萬美國人經歷與骨質疏鬆症相關的骨折,花費 190 億美元,推動了對骨質密度檢測設備的需求。全球骨質疏鬆症患者的增加預計將推動骨質密度檢測設備市場的成長。
預計未來幾年,老齡化人口的成長將推動骨質密度檢測設備市場的擴張。 「老化」是指老年人在總人口中所佔比例或百分比的不斷增加。老化影響著全球經濟、醫療保健系統和社會支持網路。老年人更容易患骨質疏鬆症,這凸顯了早期發現和預防的必要性,以及骨骼健康的重要性及其對醫療保健的影響。骨骼密度測量是診斷和治療老年人骨質疏鬆症的重要方法,有可能降低醫療成本並改善患者的預後。例如,根據美國皮尤研究中心2024年1月發布的報告,預計2024年老齡人口將達到10.1萬人,到2054年將增加至42萬人。因此,老齡化人口的成長正在推動骨質密度檢測設備市場的成長。
技術進步是骨質密度檢測設備市場的一個突出趨勢,主要企業正專注於提供先進的解決方案以滿足客戶趨勢並提升其市場地位。公司正在將下一代技術(如放射照相術、電腦斷層掃描、螢光透視、乳房X光攝影、衍射、 3D 視覺化和建模)融入他們的骨質密度檢測設備產品中。例如,義大利醫療設備製造商 Echolight SPA 使用射頻回波多光譜 (REMS) 技術提供一種創新的無輻射骨骼密度解決方案。 REMS 技術克服了 DXA 和 QUS 等傳統技術的局限性,提供了一種無輻射方法來評估腰椎和頸部的骨骼狀態。這種對技術創新的重視正在推動骨質密度檢測設備市場的發展。
骨質密度檢測設備市場的主要參與企業正在進行策略性投資以增強其能力,例如蘇黎世州銀行對 MEDIMAPS GROUP 的投資。蘇黎世州銀行向 Medimaps Group 進行了 2000 萬美元的大額投資,Medimaps Group 是一家瑞士影像處理軟體提供商,專門使用常規醫學影像進行骨骼健康評估。這項投資透過蘇黎世州銀行的資產管理部門 Swiss KantInvest 進行。瑞士企業家基金、Swisscom Ventures 和 Verve Ventures 也參與了由 Swiss KantInvest主導的此輪資金籌措。 2021 年 12 月,Medimaps Group 宣布已成功從機構投資者手中資金籌措2,000 萬美元。這筆資金旨在支持使用常規醫學影像進行骨骼健康評估的人工智慧產品組合的開發和商業化。這些資金將用於開發和推出用於骨骼健康評估的專有 AI 應用程式,並擴展其在美國、歐洲、亞洲和拉丁美洲的產品線。
2022年4月,美國社區醫院紐曼區域醫療中心 (Newman Regional Health) 與豪洛捷 (Hologic) 達成合作,將 Horizon DXA骨骼密度儀系統納入其醫療服務。此次策略夥伴關係使紐曼區域醫療中心能夠提升其為男性和女性提供的健康和福祉服務。 Horizon DXA 系統由美國診斷產品、醫學影像系統和外科產品製造商和供應商 Hologic 開發,採用先進的成像技術,可提供卓越的影像品質和尖端的診斷工具。該系統支持骨質疏鬆症的早期發現和治療,有助於改善患者的醫療效果。
骨質密度檢測設備市場上的一些主要企業包括 Diagnostic Medical Systems SA、GE Healthcare Technologies Inc.、Hologic Inc.、BeamMed Ltd.、Demetech AB、Osteometer Meditech Inc.、OSTEOSYS Corp.、Trivitron Healthcare Private Limited、Swissray International Inc.、MEDIao Healthcare Medical Ltd.、Xingao Global Etquid Limited、Swissray International Inc.、MEDIao Global Ltd.、Xingao Global Et. AB、Medonica Co.Ltd.、CyberLogic Inc.、Oscare Medical Oy、L'Acn Srl.、深圳艾克瑞電氣有限公司、YOZMA BMTech Co.Ltd.、Nanoomtech Co.Ltd.、Nanoomtech Co.Ltd.、MedANNSaboratories Inc.、Stemon Inc. Corporation、Koninklijke Philips NV 和 Samsung Medison Co. Ltd.。
2024年骨質密度檢測設備市場最大的地區是北美。預計亞太地區將成為預測期內成長最快的地區。骨質密度檢測設備市場報告涵蓋的地區包括亞太地區、西歐、中歐和東歐、北美、南美以及中東和非洲。
骨質密度檢測設備市場報告涉及的國家有澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國和美國。
骨質密度檢測設備市場包括中央DEXA和周邊DEXA的銷售。該市場的價值是「工廠門口」價值,即商品製造商或生產商銷售給其他營業單位(包括下游製造商、批發商、經銷商和零售商)或直接銷售給最終客戶的商品價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。
A bone densitometer is a medical device designed to measure bone mineral density, providing crucial information about the health of bones. Typically utilized in hospitals and diagnostic centers, a bone densitometer employs advanced X-ray technology to assess the minerals and density of bones.
Key types of bone densitometers include DXA systems (dual-energy X-ray absorptiometry), peripheral bone densitometers, radiographic absorptiometry scanners, and quantitative ultrasound scanners. DXA systems, in particular, represent an advanced form of X-ray technology used to measure bone mineral density. This technology employs a minimal dose of ionizing radiation to generate images of the inside of the body, aiding in the assessment of bone loss. Bone densitometers find application in various healthcare settings, including hospitals, clinics, diagnostic and imaging centers. They are instrumental in diagnosing conditions such as osteoporosis, osteopenia, rheumatoid arthritis, and for measuring body composition.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.
The bone densitometer market research report is one of a series of new reports from The Business Research Company that provides bone densitometer market statistics, including bone densitometer industry global market size, regional shares, competitors with a bone densitometer market share, detailed bone densitometer market segments, market trends and opportunities, and any further data you may need to thrive in the bone densitometer industry. This bone densitometer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The bone densitometer market size has grown strongly in recent years. It will grow from $1.35 billion in 2024 to $1.45 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to aging population, rise in awareness about the importance of bone health, rise in healthcare infrastructure, economic growth.
The bone densitometer market size is expected to see rapid growth in the next few years. It will grow to $2.17 billion in 2029 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to rise in preventive healthcare, rising research and development, rising healthcare spending, increasing prevalence of osteoporosis. Major trends in the forecast period include artificial intelligence (ai) integration, sustainability and green technology, wearable bone health monitoring, patient engagement solutions, remote monitoring.
The forecast of 10.7% growth over the next five years remains unchanged from the previous projection for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for dual-energy X-ray absorptiometry (DEXA) components and precision calibration phantoms, sourced from key regions such as Japan and Switzerland, which could lead to delayed osteoporosis diagnoses and increased equipment costs for healthcare facilities.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increasing incidence of osteoporosis is anticipated to drive the demand for bone densitometers. Osteoporosis, characterized by a decrease in bone density and strength leading to fragile bones, is attributed to factors such as low calcium intake, genetic disorders, and gastrointestinal surgery. Bone densitometers play a crucial role in calculating quantitative bone density through specific technologies and applications, aiding in the diagnosis and treatment of osteoporosis. With an estimated 1.5 million Americans experiencing osteoporosis-related fractures each year, costing $19 billion, as reported by Amgen in 2022, there is a heightened demand for bone densitometers. The global increase in osteoporosis cases is expected to propel the growth of the bone densitometer market.
The growing aging population is anticipated to drive the expansion of the bone densitometer market in the coming years. The term "aging population" refers to the increasing percentage and proportion of elderly individuals within the overall population. The aging population impacts the global economy, healthcare systems, and social support networks. Elderly individuals are more susceptible to developing osteoporosis, highlighting the need for early detection and prevention, as well as the significance of bone health and its implications for healthcare. Bone densitometry is a vital method for diagnosing and treating osteoporosis in older adults, with the potential to reduce healthcare costs while enhancing patient outcomes. For example, in January 2024, a report published by the Pew Research Center, a US-based organization, noted that the aging population is projected to reach 101,000 in 2024 and increase to 420,000 by 2054. Consequently, the rising aging population is propelling the growth of the bone densitometer market.
Technological advancements represent a prominent trend in the bone densitometer market, with major companies focusing on delivering advanced solutions to meet customer demands and enhance market positions. Companies are incorporating next-generation technologies, such as radiography, computed tomography, fluoroscopy, mammography, diffraction, 3D visualization, and modeling, into their bone densitometer products. For instance, Italian medical equipment manufacturer Echolight SPA offers an innovative radiation-free bone densitometry solution using Radiofrequency Echographic Multi Spectrometry (REMS) technology. REMS technology provides a radiation-free approach to assess the bone situation of the lumbar vertebral column and femoral neck, overcoming limitations of traditional techniques like DXA and QUS. This emphasis on technological innovation is driving the evolution of the bone densitometer market.
Major players in the bone densitometer market are strategically investing to enhance their capabilities, as exemplified by Zurcher Kantonalbank's investment in MEDIMAPS GROUP. Zurcher Kantonalbank made a significant investment of $20 million in Medimaps Group, a Swiss imaging software provider specializing in bone health evaluation using regular medical images. This investment was facilitated through Swisscanto Invest, Zurcher Kantonalbank's asset management arm. The financing round, led by Swisscanto Invest, also included participation from Swiss Entrepreneurs Fund, Swisscom Ventures, and Verve Ventures. In December 2021, Medimaps Group announced the successful raising of $20 million in institutional funding. This capital infusion aimed to support the development and commercialization of an artificial intelligence portfolio for bone health evaluation using routine medical images. The funds were earmarked for expanding the product line through the creation and launch of proprietary AI applications for bone health evaluation across the United States, Europe, Asia, and Latin America.
In April 2022, Newman Regional Health, a U.S.-based community hospital, forged a collaboration with Hologic to incorporate the Horizon DXA bone densitometry system into its healthcare offerings. This strategic partnership allowed Newman Regional Health to enhance its male and female health and well-being services. The Horizon DXA system, developed by Hologic, a U.S.-based manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products, is equipped with advanced imaging technology that provides excellent image quality and cutting-edge diagnostic tools. This system supports the early detection and treatment of osteoporosis, thereby contributing to improved healthcare outcomes for patients.
Major companies operating in the bone densitometer market include Diagnostic Medical Systems SA, GE Healthcare Technologies Inc., Hologic Inc., BeamMed Ltd., Demetech AB, Osteometer Meditech Inc., OSTEOSYS Corp., Trivitron Healthcare Private Limited, Swissray International Inc., MEDILINK Global Ltd., Xingaoyi Medical Equipment Co. Ltd., Echolight S.p.a, Eurotec Medical Systems srl, Scanflex Healthcare AB, Medonica Co. Ltd., CyberLogic Inc., Oscare Medical Oy, L'Acn Srl., Shenzhen Xray Electric Co. Ltd., YOZMA BMTech Co. Ltd., Nanoomtech Co. Ltd., FURUNO Electric Co. Ltd., ARTANN Laboratories Inc., StemLab Inc., CooperSurgical Inc., Medtronic PLC, Siemens AG, Canon Medical Systems Corporation, Koninklijke Philips N.V., Samsung Medison Co. Ltd.
North America was the largest region in the bone densitometer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bone densitometer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
The countries covered in the bone densitometer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.
The bone densitometer market consists of sales of central DEXA and peripheral DEXA. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Bone Densitometer Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on bone densitometer market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for bone densitometer ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The bone densitometer market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.